Broadview Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$6.23M Sell
147,275
-2,200
-1% -$95.5K 1.92% 16
2019
Q1
$7.39M Buy
149,475
+4,200
+3% +$190K 2.01% 14
2018
Q4
$6.29M Buy
145,275
+17,625
+14% +$879K 1.81% 23
2018
Q3
$7.25M Buy
+127,650
New +$6.72M 1.24% 39

Other funds holding GMED

Broadview Advisors's GMED Position: Q2 2019 in Review

Broadview Advisors reduced its Globus Medical (GMED) stake by 1.5% in Q2 2019, selling an estimated $95.5K and leaving 147,275 shares worth $6.23M. The position accounts for 1.92% of the portfolio, ranked #16.

Broadview Advisors first reported a position in GMED in Q3 2018 and has held it in 4 quarters since. The position peaked at $7.39M in Q1 2019. 259 funds tracked by Wall St. Rank hold GMED as of Q2 2019.

  • Broadview Advisors held 147,275 shares of Globus Medical worth $6.23M as of Q2 2019.
  • Broadview Advisors sold 2,200 Globus Medical shares in Q2 2019, an estimated $95.5K.
  • Globus Medical made up 1.92% of Broadview Advisors's portfolio in Q2 2019, its #16 holding.
  • Broadview Advisors first reported a position in Globus Medical in Q3 2018 and has held it in 4 quarters since.
  • Broadview Advisors's Globus Medical position peaked at $7.39M in Q1 2019.
  • 259 funds tracked by Wall St. Rank held Globus Medical as of Q2 2019.

Based on Broadview Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.